Hansen’s Disease (Leprosy): Advice and Risks for UK Travellers

Hansen’s disease, historically known as leprosy, is a chronic infectious disease caused by the bacterium Mycobacterium leprae. While the name carries significant historical stigma, modern medicine views it as a manageable and curable condition. In the United Kingdom, leprosy is exceptionally rare; the few cases diagnosed each year are typically in individuals who have lived or worked in parts of the world where the disease is still endemic, such as parts of Southeast Asia, South America, or Africa.

According to NHS guidance and Public Health England records, the disease does not spread easily between people. It is not transmitted through casual contact like shaking hands or sitting next to someone. Instead, it is thought to be spread through droplets from the nose and mouth during close and frequent contact with an untreated individual. Notably, over 95% of the global population has a natural immunity to the bacteria.

One of the most challenging aspects of Hansen’s disease is its incredibly long incubation period. Symptoms may not appear for 3 to 5 years, and in some cases up to 20 years, after exposure. For British citizens returning from long-term travel or aid work, it is important to be aware of the following signs:

• Skin Lesions: Pale or reddish patches of skin that may appear flat or slightly raised.
• Loss of Sensation: The most characteristic sign is that these skin patches often lose the ability to feel pain, heat, or touch.
• Nerve Involvement: Thickened nerves, particularly around the elbows (ulnar nerve) or knees, which may cause tingling, numbness, or muscle weakness in the hands and feet.
• Eye Issues: Dryness or reduced blinking if the nerves in the face are affected.
• Nasal Congestion: Persistent nosebleeds or a stuffy nose in advanced cases.

Where is the risk highest?

While the risk to the average UK holidaymaker is negligible, those spending extended periods (months or years) in endemic regions should practice basic health precautions. Countries with higher reported cases include India, Brazil, and Indonesia. The National Institute for Health and Care Excellence (NICE) notes that the risk is linked to prolonged, close contact in overcrowded conditions.

How to reduce your risk

There is no specific vaccine for leprosy, although the BCG vaccine (used for tuberculosis) provides some degree of cross-protection. The best prevention involves maintaining good hygiene and avoiding prolonged close contact with individuals who have untreated chronic respiratory symptoms in endemic areas. If you are working in a healthcare or humanitarian capacity abroad, ensure you follow all local health protocols and use appropriate personal protective equipment (PPE).

The outlook for someone diagnosed with Hansen’s disease in the UK is excellent. It is treated with Multi-Drug Therapy (MDT), a combination of antibiotics such as rifampicin, dapsone, and clofazimine. This treatment is highly effective and usually lasts between six and twelve months.

Once a patient starts the first few doses of MDT, they are no longer infectious to others. The primary goal of UK specialists is to clear the infection and manage any nerve inflammation (reactions) that might occur during the recovery process. Treatment is provided free of charge by the NHS through specialist infectious disease centres, such as the Hospital for Tropical Diseases in London.

If you have recently returned to the UK from a region where Hansen’s disease is prevalent and you notice a persistent skin patch that does not itch or hurt, you should seek medical advice. While many skin conditions like eczema or fungal infections are much more likely, a professional evaluation is essential for peace of mind.

Speaking to a GP online can be an effective first step. You can discuss your travel history and share images of the affected skin area. If the doctor suspects a tropical infection, they can arrange for the necessary blood tests or refer you to a local dermatology or infectious disease clinic for a skin biopsy, which is the gold standard for diagnosis. Early intervention is the key to preventing permanent nerve damage and disability.

Being diagnosed with a rare condition can be distressing. In the UK, patient confidentiality is paramount, and there is no longer a requirement for mandatory isolation, as was the case in the distant past. Support groups and specialist nurses are available to help patients navigate their treatment journey. The emphasis is on returning to normal life as quickly as possible while completing the antibiotic course to ensure the bacteria are fully eradicated.